The databook is designed to serve as a comprehensive guide to navigating this
sector. The databook focuses on market statistics denoted in the form of
revenue and y-o-y growth and CAGR across the globe and regions. A detailed
competitive and opportunity analyses related to plasma fractionation market will
help companies and investors design strategic landscapes.
immunoglobulins was the
largest segment with a revenue share of
60.85% in
2022.
Horizon Databook has segmented the Global plasma fractionation market based on albumin, immunoglobulins, coagulation factors, protease inhibitors, others (thrombin, protein c, antithrombin) covering the revenue growth of each sub-segment from 2018 to
2030.
- Global Plasma Fractionation Product Outlook (Revenue, USD Million, 2018-2030)
- Albumin
- Immunoglobulins
- Intravenous immunoglobulins
- Subcutaneous immunoglobulins
- Other immunoglobulins
- Coagulation Factors
- Factor VIII
- Factor IX
- VON WILLEBRAND FACTOR
- PROTHROMBIN COMPLEX CONCENTRATES
- FIBRINOGEN CONCENTRATES
- Others (FACTOR XIII, FACTOR XI)
- Protease inhibitors
- Others (thrombin, protein C, antithrombin)
- Global Plasma Fractionation Method Outlook (Revenue, USD Million, 2018-2030)
- Cetrifugation
- Depth Filtration
- Chromatography
- Others (ethanol Fractionaation, cryoprecipitation, ultrafiltration)
- Global Plasma Fractionation Application Outlook (Revenue, USD Million, 2018-2030)
- Neurology
- Hematology
- Oncology
- Immunology
- Pulmonology
- Others
- Global Plasma Fractionation End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals & Clinics
- Clinical Research
- Others
Reasons to
subscribe to Global plasma fractionation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of
Global plasma fractionation market databook
-
Our clientele includes a mix of plasma fractionation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed
overview of
global-level
data and insights on the Global plasma fractionation market , including
forecasts for subscribers. This
global
databook contains high-level insights into
Global plasma fractionation market from
2018 to
2030, including revenue
numbers, major trends, and company profiles.